[1] |
HASSAN S W,WAHEED M T,MÜLLER M,et al. Expression of HPV-16 L1 capsomeres with glutathione-S-transferase as a fusion protein in tobacco plastids:an approach for a capsomere-based HPV vaccine[J]. Hum Vaccin Immunother,2014,10(10):2975-2982.
|
[2] |
SCHIFFMAN M,CASTLE P E,JERONIMO J,et al.Human papillomavirus and cervical cancer[J]. Lancet,2007,370(9590):890-907.
|
[3] |
GUAN J,BYWATERS S M,BRENDLE S A,et al.Structural comparison of four different antibodies interacting with human papillomavirus 16 and mechanisms of neutralization[J]. Virology,2015,483:253-263.
|
[4] |
ROBERTS C,GREEN T,HESS E,et al.Development of a human papillomavirus competitive luminex immunoassay for 9 HPV types[J]. Hum Vaccin Immunother,2014,10(8):2168-2174.
|
[5] |
COLLIER B,OBERG D,ZHAO X,et al.Specific inactivation of inhibiotory sequence in the 5' end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells[J]. J Virol,2002,76(6):2739-2752.
|
[6] |
KIM H J,CHO S Y,PARK M H,et al.Comparison of the size distributions and immunogenicity of human papillomavirus type 16 L1 virus-like particles produced in insect and yeast cells[J]. Arch Pharm Rse,2018,41(5):544-553.
|
[7] |
韦耀,韩朋,周旋,等. A型肉毒毒素(BoNT/A)表位多肽单克隆抗体的制备及其效价评定[J]. 中国卫生检验杂志,2013,12(18):3510-3513.
|
[8] |
孙卫国,孙文娜,侯江厚,等. 人巨细胞病毒pp150-gp52蛋白原核可溶性表达与IgM捕获ELISA方法建立和应用[J]. 现代检验医学杂志,2015,30(5):1-4.
|
[9] |
谷鸿喜,凌虹,张凤民,等. 宫颈癌组织中人乳头瘤病毒16型L1基因的克隆及序列分析[J]. 中华实验和临床病毒学杂志,1999,9(1):17-19.
|
[10] |
HERRERO R,GONZÁLEZ P,MARKOWITZ L E. Present status of human papillomavirus vaccine development and implementation[J]. Lancet Oncol,2015,16(5):e206-e216.
|
[11] |
YANG X F,QU X Z,WANG K,et al.Construction of prophylactic human papillomavirus type 16 L1 capsid protein vaccine delivered by live attenuated Shigella flexneri strain sh42[J]. Acta Biochim Biophys Sin(Shanghai),2005,37(11):743-750.
|
[12] |
王爱萍,蒋敏,栗宁,等. 人乳头瘤病毒16型L1蛋白B细胞表位预测[J]. 细胞与分子免疫学杂志,2016,32(4):442-445.
|